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Pannexins (Panx) are proteins homologous to the invertebrate gap junction proteins called
innexins (Inx) and are traditionally described as transmembrane channels connecting
the intracellular and extracellular compartments. Three distinct Panx paralogs (Panx1,
Panx2 and Panx3) have been identified in vertebrates but previous reports on Panx
expression and functionality focused primarily on Panx1 and Panx3 proteins. Several
gene expression studies reported that Panx2 transcript is largely restricted to the
central nervous system (CNS) hence suggesting that Panx2 might serve an important
role in the CNS. However, the lack of suitable antibodies prevented the creation of a
comprehensive map of Panx2 protein expression and Panx2 protein localization profile
is currently mostly inferred from the distribution of its transcript. In this study, we
characterized novel commercial monoclonal antibodies and surveyed Panx2 expression
and distribution at the mRNA and protein level by real-time qPCR, Western blotting
and immunofluorescence. Panx2 protein levels were readily detected in every tissue
examined, even when transcriptional analysis predicted very low Panx2 protein expression.
Furthermore, our results indicate that Panx2 transcriptional activity is a poor predictor
of Panx2 protein abundance and does not correlate with Panx2 protein levels. Despite
showing disproportionately high transcript levels, the CNS expressed less Panx2 protein
than any other tissues analyzed. Additionally, we showed that Panx2 protein does not
localize at the plasma membrane like other gap junction proteins but remains confined
within cytoplasmic compartments. Overall, our results demonstrate that the endogenous
expression of Panx2 protein is not restricted to the CNS and is more ubiquitous than initially
predicted.
Keywords: pannexin 2, gap junction, gene transcription, protein expression, protein distribution, central nervous
system (CNS), mouse, mRNA
INTRODUCTION
Gap junction proteins are traditionally described as aqueous
plasma membrane channels which allow rapid cell-to-cell com-
munication by directly connecting the cytoplasm of adjacent cells.
In chordates, connexins (Cxs) are the canonical gap junction
proteins while gap junctions in invertebrates are formed exclu-
sively by the evolutionarily unrelated innexin (Inx) family. In
2000, another small gene family named pannexin (Panx) was
identified based on sequence homology with the Inx family and
was found to be expressed alongside Cxs in chordates (Panchin
et al., 2000). Three distinct Panx paralogs (Panx1, Panx2 and
Panx3) were initially identified in vertebrates (Panchin et al.,
2000; Panchin, 2005; Barbe, 2006) but recent studies showed
that Panx1 has been retained as two independent ohnologs in
teleost as a result of an ancestral whole genome duplication
(Bond et al., 2012; Kurtenbach et al., 2013). Despite the lack of
Abbreviations: Cx, connexin; Inx, innexin; Panx, pannexin; qPCR, quantita-
tive real-time PCR; GFAP, glial fibrillary acidic protein; HRPO, horseradish
peroxidase; DEPC, diethylpyrocarbonate; Polr2a, DNA-directed RNA poly-
merase II subunit RPB1; SDS-PAGE, sodium dodecyl sulfate polyacrylamide
gel electrophoresis; BCA, bicinchoninic acid; TCE, 2,2,2-trichloroethanol;
NCL, nitrocellulose; PB, phosphate buffer.
sequence similarity between Inxs/Panxs and Cxs, both families
share structural resemblance. Cxs and Panxs both have a pre-
dicted topology consisting of four membrane-spanning domains,
two extracellular loops, a cytoplasmic loop, and cytoplasmic
N- and C-termini (Panchin, 2005). Despite sharing structural
resemblance with Cxs, the ability of Panx channels to form gap
junctional coupling remains controversial. A few groups reported
that Panx1 and Panx3 can form cell-cell junctional channels
(Bruzzone et al., 2003; Vanden Abeele et al., 2006; Lai et al., 2007;
Ishikawa et al., 2011; Sahu et al., 2014) but their observations
were limited primarily to heterologous or over-expression systems
and undisputable evidence supporting Panx-based coupling is
still lacking. In contrast to Cxs, all three Panxs are glycosylated
at their extracellular loops (Penuela et al., 2009) with carbo-
hydrate moieties that sterically hinder the docking of channels
from adjacent cells (Boassa et al., 2007). Therefore, it is largely
accepted that under physiological conditions, Panx channels pri-
marily form non-junctional membrane channels controlling the
exchange of ions and small molecules between the cytoplasm
and extracellular space and do not significantly contribute to
direct cell-to-cell gap junctional communication (Sosinsky et al.,
2011).
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Several gene expression profiling studies reported that Panx2
transcriptional activity is largely restricted to the central nervous
system in human (Baranova et al., 2004), rat (Bruzzone et al.,
2003) and zebrafish (Zoidl et al., 2008; Bond et al., 2012). Minimal
Panx2 mRNA levels have also been detected in some non-neural
tissues such as the eye, thyroid, prostate, kidney, liver, heart
and olfactory epithelium (Bruzzone et al., 2003; Dvoriantchikova
et al., 2006; Bond et al., 2012; Zhang et al., 2012) but given
the much larger Panx2 mRNA levels found in the CNS, Panx2
transcript and corresponding protein are largely assumed to be
primarily expressed in the CNS. In the healthy brain, Panx2
protein was shown to have a complex distribution pattern and is
expressed in pyramidal cells and interneurons alike (Zappalà et al.,
2007). Interestingly, Panx2 protein was also detected in astrocytes
following ischemia in the rat but not in the healthy brain (Zappalà
et al., 2007). Panx2 protein is also present in hippocampal neural
progenitors and mature neurons both in vitro and in vivo (Swayne
et al., 2010). However, because Panx2 is believed to be primarily
CNS-specific, the mapping of Panx2 protein distribution in other
tissues has not been undertaken.
In this study, we compared Panx2 gene transcription and
protein expression profiles in mouse tissues using a combination
of real-time qPCR, Western blot and immunofluorescence. Our
results reveal that Panx2 mRNA and protein levels are not cor-
related and demonstrate that Panx2 protein expression is more
ubiquitous than initially predicted.
MATERIALS AND METHODS
ANIMAL CARE
All experiments were performed in accordance with the guidelines
established by the Canadian Council on Animal Care and were
approved by the University of British Columbia Animal Care
Committee (protocol number A11-0169).
ANTIBODIES
The two Panx2 mouse monoclonal antibodies (clones N121A/1
and N121A/31) were generated by UC Davis/NIH NeuroMab
Facility (Davis, CA, USA) using an immunogen made of the entire
rat Panx2 protein sequence (accession number P60571) minus
the first 10 amino acids. Both clones were used at 20 µg/mL
for immunofluorescence and 5 µg/mL for Western immunoblot-
ting or dot blotting. The rabbit anti-Panx1 polyclonal antibody
was generously provided by Dr. Dale Laird from the University
of Western Ontario (London, ON, Canada) and was used at
2 µg/mL for immunofluorescence and 0.4 µg/mL for Western
immunoblotting. The rabbit anti-GFAP (Sigma, St. Louis, MO,
USA) was used at 1:500. Purified immunoglobulin from non-
immunized mouse was obtained from Jackson Immunoresearch
(cat# 015-000-003; West Grove, PA, USA) and was used at the
same concentration as the anti-Panx2 antibodies. AlexaFluor- and
HRPO-conjugated goat secondary antibodies were obtained from
Invitrogen (Carlsbad, CA, USA) and Sigma (St. Louis, MO, USA)
respectively.
CELL CULTURE
Wild-type C6 glioma cells as well as C6-Panx1GFP, C6-Panx2 and
C6-Panx2GFP stable transfectants were cultured as previously
described (Lai et al., 2007, 2009). Briefly, cells were grown in low
glucose DMEM (Sigma-Aldrich, St. Louis, MO, USA) containing
10% fetal bovine serum, 10 units/mL penicillin, and 10 µg/mL
streptomycin at 37◦C and 5% CO2. Primary cultures of astro-
cytes were prepared as previously described (Le et al., 2014).
Briefly, cortices were dissected from early postnatal (P0–P1)
mouse pups, freed of meninges, minced and mechanically tritu-
rated in DMEM. The cell suspension was then strained through
a 70 µm filter and seeded into T75 flasks (2 cortices/flask).
Cells were cultured in DMEM (Sigma-Aldrich, St. Louis, MO,
USA) containing 10% fetal bovine serum, 10 units/mL peni-
cillin, and 10 µg/mL streptomycin at 37◦C and 5% CO2 and
the medium was initially replaced 3 days after plating and every
other day subsequently. After 7–8 days, the flasks were vigorously
shaken to remove loosely attached cells and primary astrocytes
were harvested with trypsin-EDTA (Invitrogen, Carlsbad, CA,
USA) and frozen in DMEM, 10% FBS, and 8% DMSO. Frozen
astrocytes were thawed and plated on glass coverslips coated
with poly-L-ornithine (0.01% solution, Sigma-Aldrich, St. Louis,
MO, USA). Cultures were maintained for 5, 10 or 15 days
prior to staining. The percentage of Panx2-positive astrocytes
was defined as the number of cells that stained positively for
Panx2 divided by the number of nuclei. For each time point,
that ratio was calculated by averaging the values obtained from
three coverslips with 10 field of views (168 × 225 µm) per
coverslip.
EPITOPE MAPPING
A library of 70 overlapping peptides covering the entire sequence
of the rat Panx2 (Uniprot accession number P60571) minus
the four transmembrane domains was obtained from Genscript
(Piscataway, NJ, USA). Peptides were 15 amino acids in length
with a 7 amino acids overlap. A total of 100 µg of peptide was
pre-incubated overnight at 4◦C in 100 µL of dot-blot buffer
(8 M Urea, 100 mM NaH2PO4, 10 mM Tris, pH 8.0) con-
taining 10 µg bovine serum albumin. Peptides were then dot-
blotted on nitrocellulose membrane (Bio-Rad, Hercules, CA,
USA), washed with sodium phosphate buffered saline (PBS, pH
7.4), dried at 37◦C and blocked for 1 h in milk solution (4%
nonfat milk, 20 mM Tris, 150 mM NaCl pH 7.4). The mem-
brane was then immunoprobed for 2 h at room temperature
with the primary antibody followed by HRPO-conjugated sec-
ondary antibodies (Sigma, St. Louis, MO, USA) for 1 h at room
temperature.
RNA ISOLATION AND REAL-TIME QUANTITATIVE PCR
Three 3–5 month old mice were deeply anesthetized by
intraperitoneal injection of sodium pentobarbital and perfused
transcardially with 10–15 mL of PBS (pH 7.4) followed by
10–15 ml of aqueous ammonium sulfate solution (5.3 M
ammonium sulfate, 25 mM sodium citrate, 10 mM EDTA,
pH5.2) to precipitate degenerative RNases. Organs were rapidly
harvested and stored at −80◦C in the same solution. Total
RNA was harvested from 50 mg of tissue using Trizol Reagent
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
directions. Air-dried RNA samples were re-solubilized in DEPC-
treated double distilled H2O and RNA quantity and purity was
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assessed using a NanoDrop 1000 Spectrophotometer (Thermo
Scientific, Waltham, MA, USA). All samples had A260/280 and
A260/230 ratios above 1.9 and 2.3 respectively. A total of 500 ng
per sample was reverse transcribed into cDNA in a 10 µL reaction
volume using qScript (Quanta Biosciences, Gaithersburg, MD,
USA) according to the manufacturer’s instructions. Real-time
qPCR was performed in 18 µL reaction volume containing 45 ng
of cDNA and 0.4 µM primers diluted in 2× Fast Plus EvaGreen®
qPCR Master Mix (Biotium Inc., Hayward, CA, USA). The
following primer pairs were used to amplify Panx2 cDNA
(forward 5′-AGAAGGCCAAGACTGAGGCG-3′ and reverse
5′- GGAGCATCTTTGGTGGGTGC-3′) and the reference gene
DNA-directed RNA polymerase II subunit (RPB1) (Polr2a) cDNA
(forward 5′- AGCTGGTCCTTCGAATCCGC-3′ and reverse
5′- TGGACTCAATGCATCGCAGGA-3′). Primers were designed
to span an exon junction to prevent amplification of genomic
DNA. Samples were amplified in duplicate using the CFX96 Real-
Time PCR Detection System (Bio-Rad, Hercules, CA, USA) with
the following cycling scheme: 2 min at 95◦C followed by 50 cycles
consisting of 5 s denaturation at 95◦C, 5 s annealing at 60◦C and
25 s elongation at 72◦C. Raw data were exported as text files and
analyzed with the qPCR package for R (Ritz and Spiess, 2008).
Amplification efficiencies and Cy0 crossing points (Guescini et al.,
2008) were calculated from a 5-parameter log-logistic model
fitted to the raw fluorescence data to accommodate asymmetrical
amplification curves (Spiess et al., 2008). Values from duplicated
qPCR runs were averaged. Expression ratios were calculated from
three biological replicates by the Pfaffl method to correct for
variation in PCR efficiency (Pfaffl, 2001) and normalized against
the reference gene Polr2a. Spinal cord mRNA levels were used as
baseline to compare Panx2 expression across tissues. Propagation
of error was estimated by a Monte Carlo simulation with 10,000
iterations as described in the qPCR package documentation.
PROTEIN ISOLATION ANDWESTERN BLOTTING
Organs were quickly collected after transcardial perfusion with
PBS, flash frozen in liquid nitrogen and stored at −80◦C until
needed. Tissues or cells were homogenized in RIPA buffer
(150 mM NaCl, 50 mM Tris-HCl pH 8.0, 0.5% Sarkosyl, 1%
IGEPAL, 0.1% SDS) containing protease inhibitors (Pierce, Rock-
ford, IL, USA) and phosphatase inhibitors (Sigma, St. Louis,
MO, USA). Protein concentration was determined using a bicin-
choninic acid (BCA) assay kit (Pierce, Rockford, IL, USA) and
50 µg was separated on 10% Tris-glycine SDS-PAGE gels con-
taining 0.5% 2,2,2-trichloroethanol (TCE; Sigma, St. Louis, MO,
USA). Upon electrophoresis completion, protein bands were
visualized at 300 nm on an AlphaImager 3400 transilluminator
(AlphaInnotech, San Leandro, CA, USA) as previously described
(Ladner et al., 2004) and electroblotted on nitrocellulose (NCL)
membrane (Bio-Rad, Hercules, CA, USA). Protein bands on
NCL were re-visualized under UV for quantification and total
protein normalization (Gürtler et al., 2013). For analysis which
did not require quantification, TCE was omitted and PVDF mem-
branes were used (Bio-Rad, Hercules, CA, USA). Membranes
were blocked at room temperature for 1 h in milk solution
(4% nonfat milk, 20 mM Tris, 150 mM NaCl, pH 7.4) and
probed with primary antibodies at 4◦C overnight followed by
HRPO-conjugated secondary antibodies (Sigma, St. Louis, MO,
USA) for 1 h at room temperature. All antibodies were diluted in
blocking solution. HRPO activity was visualized with Amersham
ECL Prime Western Blotting Detection Reagent (GE Healthcare
Life Sciences, Pittsburgh, PA, USA) or SuperSignal West Femto
Chemiluminescent Substrate (Thermo Scientific, Waltham, MA,
USA) and exposed on Bioflex Econo films (Clonex, Markham,
ON, Canada). Image acquisition for Western blot quantification
was done as previously described (Gassmann et al., 2009). Briefly,
film images were acquired on an AlphaImager 3400 (AlphaIn-
notech, San Leandro, CA, USA) under stable transillumination
and fitted with CCD camera lacking automatic gain control. Final
16-bit 1392×1040 pixel images were corrected for shading to
compensate for non-homogenous illumination and densitometry
analysis was performed using the Image Studio Lite software
(LI-COR, Lincoln, NE, USA). Panx2 protein ratios were calcu-
lated by dividing the band density of each tissue by the band
density of the spinal cord. A tissue lysate from spinal cord was
resolved on each gel to permit between gel comparisons. Panx2
protein ratios were calculated from three independent biological
replicates.
IMMUNOFLUORESCENCE
Three 3–5 month old mice were transcardially perfused with
PBS followed by 10–15 mL 10% formalin (Fisher) or 4%
paraformaldehyde (PFA) in PBS. Tissues were rapidly harvested
and postfixed overnight at 4◦C in the same fixative. Tissues
were equilibrated at 4◦C in 30% sucrose in PBS containing
0.05% sodium azide for cryoprotection, embedded in Tissue-
Tek O.C.T. compound (Sakura Finetek, Torrance, CA, USA),
frozen, cryosectioned at 10 µm thickness and air-dried. Tis-
sue sections were rehydrated in 0.1 M phosphate buffer (PB,
pH 7.4), post-fixed with 4% PFA for 10 min and washed
twice with PB. Antigen retrieval was performed by incu-
bating the sections in 10 mM sodium citrate (pH 8.5) at
80◦C for 30 min. Sections were cooled to room tempera-
ture, washed with PB and treated with 1% sodium borohy-
dride in PB for 30 min. After several washes in PB, samples
were blocked for 1 h at room temperature with 5% goat
serum in PB containing 0.2% Triton X-100 and incubated
overnight at 4◦C in primary antibody diluted in 1% goat
serum in PB. Sections were then washed in PB and incu-
bated for 1 h at room temperature with the appropriate Alex-
aFluor 488 or 568 secondary antibodies (Invitrogen, Carlsbad,
CA, USA), followed by mounting in ProLong Gold antifade
reagent with DAPI (Invitrogen). Cells grown on coverslips
were simply fixed with 4% PFA for 15–20 min prior block-
ing and immunostaining. Imaging was performed on a Leica
TCS SP5 confocal microscope (Leica, Mannheim, Germany).
When indicated, images were further processed with an iter-
ative Lucy-Richardson deconvolution algorithm (Vonesch and
Unser, 2008). All images were displayed as individual opti-
cal sections taken from a z-stack and not as maximal projec-
tion. All image acquisition and post-acquisition processing steps
were kept constant when comparing sections stained with anti-
Panx2 antibodies and immunoglobulins from non-immunized
animal.
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FIGURE 1 | Specificity of two novel anti-Panx2 monoclonal
antibodies. Two anti-Panx2 monoclonal antibodies (clones N121A/1 and
N121A/31) showed high specificity both in Western blot (A,C) and
immunolabeling (B). (A) Both clones detected a single band of the
proper size in C6 cells overexpressing Panx2 but did not cross-react
with Panx1 or identify unspecific protein bands in wild-type C6 cells.
The molecular weight of the protein identified by both clones shifted by
∼27 kDa when the Panx2 C-terminal was tagged with GFP (black
arrowheads). Interestingly, the avidity of clone N121A/1 was drastically
reduced when the Panx2 was tagged with GFP. This is explained by
the fact that clone N121A/1 recognizes an epitope immediately adjacent
to the GFP tag (Figure 2). (B) Immunolabeling signal from both clones
co-localized with GFP fluorescence emitted from Panx2GFP but not
Panx1GFP when expressed in C6 cells. Immunoglobulin from
non-immunized mouse did not give any signal thereby ruling out the
possibility of unspecific binding of mouse IgG. Scale bars = 20 µm.
(C) Both clones were equally specific in Western blot performed with
various tissue lysates and identified a protein of ∼70 kDa. The
occasional detection of a ∼50 kDa band in some tissues suggest that
the antibodies might recognize Panx2 degradation products or
alternatively that the anti-mouse secondary antibody detects
endogenous immunoglobulin heavy chains.
RESULTS
CHARACTERIZATION OF TWO NOVEL MONOCLONAL ANTIBODIES
SPECIFIC FOR Panx2
We initially characterized the selectivity of two novel anti-Panx2
monoclonal antibodies (N121A/1 and N121A/31) by showing
that both clones identified a single band of the proper size in
C6 cells overexpressing rat Panx2 (Figure 1A). Importantly, none
of the antibody cross-reacted with Panx1 (Figure 1A) which has
been shown to be co-expressed with Panx2 in the CNS (Vogt et al.,
2005). Selectivity was further supported by an electrophoretic
mobility assay showing that the band identified by both clones
shifted by ∼27 kDa when the Panx2 C-terminal tail was tagged
with GFP (Figure 1A). Intriguingly, tagging Panx2 with GFP
decreased the avidity of clone N121A/1. Using a library of over-
lapping peptides covering the amino acid sequence of Panx2, we
mapped the epitope of clone N121A/1 to the last 15 amino acids
of the Panx2 C-terminal tail (Figure 2). It is therefore likely that
the addition of a GFP tag adjacent to the epitope caused steric
hindrance and reduced the avidity of clone N121A/1. We also
tested the antibodies by immunofluorescence and showed that the
labelling from both clones overlapped with the GFP fluorescence
signal emitted by Panx2-GFP but not by Panx1-GFP (Figure 1B).
To test whether the novel antibodies could also be used
on samples expressing endogenous Panx2 protein we immuno-
probed protein lysates prepared from eight tissues and separated
by SDS-PAGE (Figure 1C). Our results show that both clones
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 392 | 4
Le Vasseur et al. Ubiquitous pannexin 2 protein expression
FIGURE 2 | Clone N121A/1 recognizes an epitope located within the
last 15 amino acids of the Panx2 C-terminal. (A) A library of 70
overlapping peptides spanning the entire Panx2 amino acid sequence
minus the four transmembrane domains was dot blotted (A1 to J6) and
immunoprobed with the N121A/1 anti-Panx2 antibody. A total of 25 µg of
protein lysate from wild-type C6 and C6Panx2 glioma cells (K6 and L6
respectively) was also dot blotted alongside peptides to provide negative
and positive control respectively. The clone N121A/1 specifically recognized
C6Panx2 protein lysate and peptide J6 corresponding to the last 15 amino
acids of the Panx2 C-terminal (TFEEPRTVVSTVEF). (B) Densitometry
analysis of the dot blot staining shown in (A). Only peptide J6 showed
signal above threshold. Values were normalized against the density of the
C6Panx2 sample. (C) The epitope identity was further confirmed by a
blocking peptide assay. Pre-absorbing the N121A/1 anti-Panx2 antibody with
a 200- or 1000-fold molar excess of peptide J6 dramatically reduced
immunolabeling while pre-absorption with a peptide randomly selected
along the Panx2 amino acid sequence (peptide A3) did not alter the
labeling intensity. Scale bars = 20 µm.
recognized a band of approximately 70 kDa corresponding to
the expected size of endogenous Panx2 as previously reported
(Zappalà et al., 2007; Figure 1C). Overall our results identi-
fied two different commercial monoclonal antibodies specific
for Panx2. Both clones recognize rat and mouse Panx2 and we
also successfully used clone N121A/1 to detect human Panx2
(data not shown). To avoid redundancy and because both clones
were equally specific we selected clone N121A/1 for subsequent
analysis.
Panx2 HAS A UBIQUITOUS PROTEIN EXPRESSION PROFILE
Interestingly our initial results showed substantial Panx2 protein
amount outside the nervous system (Figure 1C). To further
compare the Panx2 protein expression profile of different tissues,
we carried out semi-quantitative densitometry analysis on protein
lysates obtained from 16 tissues, separated by SDS-PAGE and
immunoprobed for Panx2 (Figure 3A). Because the expression of
common reference proteins was subjected to important fluctua-
tions across tissues (data not shown), a stain-free total protein
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FIGURE 3 | Panx2 protein is ubiquitously expressed. (A) Panx2 protein
levels were semi-quantified in 16 tissues using stain-free total protein
quantification to normalize protein levels across samples. Following exposure
to TCE and UV, protein bands electroblotted on nitrocellulose (NTC) were
visualized by fluorescence (TCE, second panel) and loading normalization (LN)
was performed by dividing the fluorescence density from an entire individual
lane by the total fluorescent density measured from the spinal cord lane on
the corresponding NTC membrane (LN, third panel). Normalized Panx2
protein ratios were expressed relative to Panx2 levels found in the spinal cord
(fourth panel). (B) Panx2 protein ratios were calculated from three different
mice (relative to spinal cord, red dots represent mean values). Panx2 protein
levels were lower in the CNS than any other tissues.
FIGURE 4 | Panx2 transcriptional activity does not correlate with
protein levels. (A) Panx2 mRNA levels were measured by real-time qPCR
in 16 tissues and expressed relative to Panx2 mRNA levels found in the
spinal cord. Error propagation was estimated by a Monte Carlo simulation
and data distribution represented using a combination of violin and box
plots (red dots represent mean values). Data were plotted on a logarithmic
scale. Panx2 mRNA levels were several orders of magnitude higher in the
CNS than in any other tissues. (B) Panx2 protein and mRNA levels were
not correlated. No significant correlation was observed even after values
from the CNS were eliminated (inset).
normalization strategy was employed to control for even load-
ing as previously described (Ladner et al., 2004; Gürtler et al.,
2013). Briefly, we incorporated TCE in the gel formulation which,
upon ultraviolet (UV) irradiation, catalyzes a covalent reaction
with tryptophan residues. This reaction emits fluorescence that
can be imaged and documented in gel and following protein
transfer on membranes (Ladner et al., 2004; Gürtler et al., 2013).
The Panx2 staining density for each tissue was then normalized
against the intensity of the TCE-fluorescence measured for the
entire lane after protein transfer on nitrocellulose membrane
(Figure 3A). Our data indicate that Panx2 protein is present at
substantial levels in every tissue studied (Figures 3A,B). More
surprisingly, in contradiction with current predictions, Panx2
protein was lower in the nervous system than in any other tissues
(Figure 3B).
TRANSCRIPTIONAL ACTIVITY DOES NOT PREDICT Panx2 PROTEIN
LEVELS
Gene profiling studies have reported that Panx2 mRNA expres-
sion is largely restricted to the CNS in human (Baranova et al.,
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FIGURE 5 | Panx2 protein is expressed in the gastrointestinal tract.
Sections of mouse stomach (A) small intestine (B) and colon (C) were
stained with an immunoglobulin from non-immunized mouse (Mouse IgG
panels) or the N121A/1 monoclonal anti-Panx2 antibody (anti-Panx2 and
Deconvolved/DIC panels). Panx2 protein was heavily expressed in the parietal
(asterisk) and epithelial (arrow) cells of the stomach (A) and the epithelial cells
of the small (B) and large (C) intestine. Panx2 distribution was primarily
perinuclear and cytoplasmic. No specific staining was observed with the IgG
from non-immunized mouse. Putative lymphocytes expressing endogenous
immunoglobulins were occasionally labeled by the anti-mouse secondary
antibody (arrowheads). (D) Panx1 and Panx2 showed distinct subcellular
distribution in the colon. Scale bars: 20 µm.
2004), rat and mouse (Bruzzone et al., 2003; Dvoriantchikova
et al., 2006) and zebrafish (Zoidl et al., 2008; Bond et al., 2012)
but a similar profiling study has not been completed in mouse.
To determine whether our observations on Panx2 protein expres-
sion could be explained by species-specific Panx2 transcriptional
activity, we compared the Panx2 transcription profile using RNA
isolated from 16 mouse tissues, reverse-transcribed into cDNA
and analyzed by real-time qPCR. Although primers were designed
to span an exon junction, end-point PCR was initially performed
using non-transcribed RNA as template to confirm the absence
of genomic DNA amplification (data not shown). We also tested
the specificity of our primer pair by visualizing the amplification
product by gel electrophoresis and by analyzing the amplicon’s
melting curve (data not shown). Our results are in accordance
with previous studies (Bruzzone et al., 2003; Baranova et al., 2004;
Dvoriantchikova et al., 2006; Zoidl et al., 2008; Bond et al., 2012)
and showed that Panx2 transcriptional activity largely predom-
inates in the CNS (Figure 4A). Panx2 transcript levels detected
in non-neural tissues were several orders of magnitude lower
than in the CNS (Figure 4A). Furthermore, we demonstrated that
there is no significant correlation between Panx2 transcript and
corresponding protein levels (Figure 4B).
Our results showed that Panx2 mRNA and protein levels
are not correlated when compared across different tissues but
does not exclude a possible correlation within a specific tissue
as opposed to between different tissues. This scenario appears
unlikely however as we have shown that Panx2 protein levels
remain surprisingly constant in the brain over a developmental
period during which Panx2 mRNA levels have been shown to
be temporally up-regulated (data not shown) (Vogt et al., 2005).
Overall, these results suggest that regulatory mechanisms unre-
lated to transcriptional activity must also control Panx2 protein
levels and indicate that Panx2 protein levels cannot be directly
inferred from the quantification of its transcript levels.
Panx2 PROTEIN IS LOCALIZED TO CYTOPLASMIC COMPARTMENTS
We next characterized the expression and distribution of Panx2 in
different tissues by immunofluorescence. In the gastrointestinal
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FIGURE 6 | Cuboidal cell from kidney tubule express Panx2 protein.
Sections of mouse kidney labeled with an immunoglobulin from
non-immunized mouse (Mouse IgG left panel) or the N121A/1 monoclonal
anti-Panx2 antibody (middle and right panels). Panx2 protein was distributed
in the cytoplasm of the epithelial cells lining the lumen of renal tubule but
was not discernible at the plasma membrane. Scale bars: 20 µm.
tract, an important population of glandular and epithelial cells
displayed strong Panx2 immunoreactivity (Figure 5). Parietal
cells, which secrete gastric acid, and the apical surface of
epithelial cells of the stomach were strongly reactive for Panx2
(Figure 5A). In the small and large intestine, a population of
columnar epithelial cells were also strongly reactive for Panx2
(Figures 5B,C). As Panx1 has also been shown to be expressed
in the columnar epithelial cells of the human colon (Diezmos
et al., 2013), we tested whether Panx1 and Panx2 could co-
localize in these cell types. Interestingly, Panx1 and Panx2
did not co-localize but showed quite different subcellular dis-
tribution patterns (Figure 5D). Panx1 expression was largely
restricted to the plasma membrane between the epithelial cells.
In contrast, Panx2 was not discernible at the plasma mem-
brane but remained largely confined to the cytoplasmic area
(Figure 5D).
In the kidney, cuboidal cells forming the single layered
epithelium of tubules were strongly labeled (Figure 6) whereas
glomeruli cells were not (data not shown). Panx2 staining was
predominantly cytoplasmic and could not be detected at the
plasma membrane. Similarly, germ cells from testis seminiferous
tubules showed abundant perinuclear and cytoplasmic but no
plasma membrane staining (Figure 7).
Panx2 immunoreactivity displayed a distinct pattern in the
mouse retina (Figure 8). Photoreceptor inner segments protrud-
ing into the subretinal space were densely decorated with Panx2-
labeled aggregates (Figure 8). Only sparse immunoreactivity was
observed in the outer nuclear layer which forms the compact
layer containing photoreceptor cell bodies (Figure 8). Substan-
tial staining was also observed in the outer plexiform layer
which comprises a dense network of neuronal synapses formed
between photoreceptors and bipolar and horizontal cell dendrites
(Figure 8).
Despite showing lower Panx2 protein levels than any other
tissues (Figure 3), Panx2 immunoreactivity was easily distin-
guishable by immunofluorescence in the CNS (Figure 9) and
showed a complex expression pattern as previously reported
(Zappalà et al., 2007). Panx2 was widely distributed in the
cytoplasm of neurons throughout the CNS but was not
readily detected in astrocytes in vivo (Figures 9A–C). Inter-
estingly, we showed that the majority of primary astro-
cytes (63.8 ± 0.9%) expressed cytoplasmic Panx2 at 5 days
in vitro (Figure 9D). However, the percentage of Panx2-
positive astrocytes rapidly declined after 10 and 15 days
in vitro (6.9 ± 1.2% and 7.3 ± 1.1%) hereby suggest-
ing that Panx2 is expressed by immature but not mature
astrocytes. That observation could explain the up-regulation
of Panx2 expression seen in astrocytes following ischemia
(Zappalà et al., 2007) as ischemia is characterized by astrocyte
proliferation.
DISCUSSION
This study reveals that Panx2 protein is more ubiquitous
than initially predicted. By performing real-time qPCR and
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FIGURE 7 | Germ cells from mouse testis express Panx2 protein.
Sections of mouse testis were labeled with an immunoglobulin from
non-immunized mouse (Mouse IgG panel) or the N121A/1 monoclonal
anti-Panx2 antibody (anti-Panx2 and Deconvolved/DIC panels). Panx2
protein was localized in the cytoplasm of germ cells in the
seminiferous epithelium. Smooth muscle cells (arrow) and interstitial
tissue (asterisk) showed high autofluorescence levels. Scale bars:
20 µm.
semi-quantitative Western blot analysis on a panel of mouse
tissues, we showed that fluctuations in Panx2 mRNA abundance
do not predict changes in Panx2 protein levels. We showed
that Panx2 protein levels are surprisingly more abundant in
non-neural tissues than in the CNS; an observation opposite
to Panx2 transcriptional activity which is weak in non-neural
tissues and largely predominant in the CNS. The ubiquitous
expression of Panx2 protein suggests a more fundamental func-
tion than the CNS-specific role which was originally proposed.
Although the exact function of Panx2 remains elusive, based
on our in vivo immunofluorescence results we hypothesize that
Panx2 channels do not significantly contribute to communica-
tion exchange between the intracellular and extracellular spaces
but rather control intracellular signaling through cytoplasmic
compartments.
ABSENCE OF CORRELATION BETWEEN Panx2 mRNA AND PROTEIN
LEVELS
The initial Panx2 gene expression profiles were obtained from
Northern blots using commercial rat (Bruzzone et al., 2003)
and human (Baranova et al., 2004) mRNA. Although notable
differences exist between the two studies, both groups reported
that Panx2 mRNA is largely predominant in the CNS; an obser-
vation that was subsequently confirmed in zebrafish using real-
time qPCR (Zoidl et al., 2008; Bond et al., 2012). Our results
show that Panx2 mRNA follows a similar expression profile in
the mouse since Panx2 transcript levels are 40 to over 1600 times
higher in the CNS than in other tissues. Because of this dramatic
disparity in Panx2 mRNA expression it has long been assumed
that Panx2 protein was preferentially, if not exclusively, expressed
in the CNS.
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FIGURE 8 | Panx2 protein is expressed in the photoreceptor inner
segment and outer plexiform layer of the mouse retina. Sections
from mouse retina were labeled with an immunoglobulin from
non-immunized mouse (Mouse IgG panel) or the N121A/1 monoclonal
anti-Panx2 antibody (anti-Panx2 and Deconvolved/DIC panels). Panx2
protein was primarily expressed in the photoreceptor inner segment (IS)
(inset a) or the outer plexiform layer (OPL) (inset b). Panx2 clustered in
small to large aggregates which appeared to be primarily cytoplasmic.
However, because of the high degree of cellular compaction we could
not reach definitive conclusions regarding Panx2 subcellular distribution
in the retina. OS: photoreceptor outer segment, IS: photoreceptor inner
segment, ONL: outer nuclear layer, OPL: outer plexiform layer, INL:
inner nuclear layer, IPL: inner plexiform layer, GCL: ganglion cell layer.
Scale bars: 20 µm.
However, in almost every organism steady-state transcript
concentrations only partially correlate with protein expression
levels (de Sousa Abreu et al., 2009) and the assumption that
transcripts can predict protein abundances has been heavily chal-
lenged. Post-transcriptional regulatory mechanisms have over-
whelming influence on changes observed at the proteome level
(Foss et al., 2011) and protein levels cannot be accurately extrap-
olated from transcript levels because several factors unrelated to
transcriptional control also directly influence protein levels. For
example, protein degradation rate has been shown to influence
the correlation between transcripts and corresponding protein
levels as stable proteins are less affected by perturbations in
mRNA levels than proteins with high turnover rates (Raj et al.,
2006). Hence, the long half-life of Panx proteins (Penuela et al.,
2007) could efficiently buffer important fluctuations in mRNA
levels and decrease the impact of Panx2 transcripts on Panx2
protein levels. Bearing this information in mind, it is safe to affirm
that variations of Panx2 transcript levels should be interpreted
restrictively, without assuming equivalent changes at the protein
level.
Mass-spectrometry-based proteomics can perform large-scale
unbiased analyses of biological systems and examine which
genes are translated into proteins in specific tissues. Recently,
two groups assembled and published mass-spectrometry-based
drafts of the human proteome into databases available online
for real-time analysis (Kim et al., 2014; Wilhelm et al., 2014).
Interestingly, unique Panx2 peptides were identified in the ileum,
colon and ovary (Wilhelm et al., 2014) as well as the gut,
spinal cord, urinary bladder, liver, ovary, testis and prostate
(Kim et al., 2014). Although substantial improvements are still
needed to achieve a complete and quantitative proteome coverage,
these independent studies nonetheless corroborate our results
and demonstrate that Panx2 protein expression is not restricted
to the CNS.
It is important to note that Panx2 protein ratios showed
high variability in some tissues (Figure 3B). This is more
likely attributable to the limited dynamic range of the
chemiluminescence technique that was used for the quantification
of Panx2 protein expression. An alternative would have been to
use a ratiometric analysis based on infrared detection of protein
bands to increase the linear detection range and increased repro-
ducibility (Zellner et al., 2008).
Panx2: A CYTOPLASMIC UNUSUAL SUSPECT
Technical reasons such as prevalent autofluorescence prevented
the analysis of certain tissues by immunofluorescence. Nonethe-
less, our study shows that Panx2 protein was heavily distributed
in the cytoplasmic compartment and could not be readily
detected at the plasma membrane in all tissues analyzed by
immunofluorescence (9 out of 16) or in cultured primary astro-
cytes expressing endogenous Panx2 protein. Previous studies
had reported cytoplasmic Panx2 in transfected overexpression
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FIGURE 9 | Panx2 protein localizes in the cytoplasm of CNS neurons.
Panx2 heavily labeled the cytoplasm, but not the plasma membrane, of
cortical neurons (A) Purkinje cells (B) and spinal cord motoneurons (C). Panx2
was not detected in GFAP-positive astrocytes in the brain (data not shown) or
the spinal cord (C) but was detected in over 60% of primary astrocytes
cultured for 5 days (D). Scale bars: 20 µm.
systems (Lai et al., 2009; Penuela et al., 2009; Bhalla-Gehi et al.,
2010) or in neurons and neural progenitor cells (Zappalà et al.,
2007; Swayne et al., 2010) but we are the first group to iden-
tify endogenous cytoplasmic Panx2 in such a large variety of
tissues.
The unique intracellular distribution of Panx2 protein is
in striking contrast with Panx1 and Panx3 proteins which are
primarily localized at the plasma membrane (Penuela et al.,
2007, 2009; Bhalla-Gehi et al., 2010). The cellular localiza-
tion of Panx proteins is influenced by glycosylation (Penuela
et al., 2009). All three Panx paralogs are glycosylated to a
high mannose form in the endoplasmic reticulum (ER; Penuela
et al., 2009; Bhalla-Gehi et al., 2010) but interestingly only
Panx1 and Panx3 proteins form complex glycoprotein species
requiring post-translational modifications occurring in the Golgi
(Penuela et al., 2009; Bhalla-Gehi et al., 2010). Panx1 and
Panx3 proteins follow a COPII-dependent ER to Golgi secre-
tory pathway prior to being trafficked to the plasma mem-
brane (Bhalla-Gehi et al., 2010). In contrast, the absence of
complex glycosylated Panx2 suggests Panx2 protein follows a
different trafficking pathway which might not involve tran-
sition through the Golgi and subsequent trafficking to the
plasma membrane. Intriguingly, Panx2 has been shown to co-
localize with the endolysosomal enriched mannose-6-phosphate
receptor in N2a neuroblastoma cells expressing Panx2 tagged
with GFP (Wicki-Stordeur et al., 2013). However, the study
used transient overexpression of tagged Panx2 protein which
might have resulted in the accumulation of misfolded or mis-
assembled proteins and increased the likelihood of artifactual
missorting in endomembrane compartments. Therefore, addi-
tional localization studies detecting endogenous Panx2 protein
using a combination of different approaches are still needed
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for the accurate identification of Panx2-positive cytoplasmic
compartments.
Others have detected putative Panx2 at the plasma mem-
brane of mature primary hippocampal neurons (Swayne et al.,
2010) or in cell types overexpressing Panx2 (Ambrosi et al.,
2010). The ectopic expression of Panx1 and Panx2 in NRK
cells has also been shown to increase Panx2 trafficking to the
plasma membrane (Penuela et al., 2009). However, the phys-
iological relevance of this increase in Panx2 at the plasma
membrane is unclear because Panx1/Panx2 heteromeric chan-
nels are unstable (Ambrosi et al., 2010). Although we cannot
exclude the possibility that undetectable levels of Panx2 are dis-
tributed at the plasma membrane in some cell types, we conclude
that under physiological conditions Panx2 protein is primarily
localized in the cytoplasmic compartment in most, if not all,
tissues.
Gap junctions have traditionally been described as plasma
membrane channels connecting the cytoplasm of adjacent cells
or controlling the exchange of small molecules between the
intracellular and extracellular spaces. Our results suggest that a
different model must apply to Panx2 because its range of action
seems to be restricted to the cytoplasmic milieu. Consequently, we
hypothesize that Panx2 can modulate cell activity through non-
conventional routes and novel intracellular signaling pathways. In
that aspect, it is interesting to note that over-expression of Panx1
and Panx3 can form calcium permeable channels in the ER (Van-
den Abeele et al., 2006; Ishikawa et al., 2011). As over-expression
of Panx2 in C6 cells showed a prominent signal overlap with the
ER (Lai et al., 2009) it is possible that Panx2 can also modulate
ER calcium signaling. Moreover, although an essential property of
gap junction proteins is their ability to oligomerize to form trans-
membrane channels, it should be emphasized that gap junctions
also have channel-independent functions. For example, connexin
43 (Cx43) has recently been shown to control the biogenesis of
autophagosomes through the sequestration of several autophagy-
related proteins (Bejarano et al., 2014); a function independent of
Cx43 channel activity. Since Panx2 has a long C-terminal tail (301
a.a) it is reasonable to suggest that protein-protein interactions
involving its C-terminus are likely to play an important role in the
function of Panx2. However, until the exact nature of Panx2 sub-
cellular compartment remains unknown, formulating hypothesis
regarding the function of Panx2 remains rather difficult.
Our understanding of Panx2 protein currently assumes that
Panx2 function can be extrapolated from our knowledge of the
other Panx proteins. More precisely, Panx2 is often perceived
as a CNS-specific protein assuming a role complementary, if
not redundant, to the function of Panx1 channel. However, our
study shows that this assumption is misleading and unlikely to
increase our knowledge on any of the Panx channels. Prior to
our work, several studies investigating the role of Panx channels
outside of the CNS focused exclusively on Panx1 and Panx3 but
completely neglected the potential implication of Panx2. As our
study shows that Panx2 protein expression is more ubiquitous
than initially predicted it would be interesting to revisit these
original studies while taking into account the presence of Panx2.
This is especially important in the context of Panx1 knockout
mice since the deletion of Panx1 could have compensatory effects
by altering the expression level of Panx2. Another cautionary note
needs to be highlighted regarding the techniques that are currently
used to assay Panx2 functionality. Several studies use patch-
clamping of the plasma membrane to address the functionality
of Panx2 channels (for example see Bargiotas et al., 2011; Poon
et al., 2014). Although we cannot totally exclude the presence
of Panx2 at the plasma membrane, our study nonetheless shows
that Panx2 protein is predominantly in cytoplasmic compart-
ments. Consequently, Panx2 channel properties cannot be solely
investigated through electrophysiological recordings at the plasma
membrane.
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